Dolph Houben

93 Outcomes of vascularized bone allotransplantation 4 38. Diefenbeck, M., A. Nerlich, S. Schneeberger, et al., Allograft vasculopathy after allogeneic vascularized knee transplantation. Transplant International, 2011. 24 (1). 39. Issa, F., Vascularized composite allograft-specific characteristics of immune responses. Transpl Int., 2016. 29 (6): p. 672-81. doi: 10.1111/tri.12765. Epub 2016 Mar 21. 40. Siemionow, M. and A. Klimczak, Basics of immune responses in transplantation in preparation for application of composite tissue allografts in plastic and reconstructive surgery: part I. Plast Reconstr Surg., 2008. 121 (1): p. 4e-12e. doi: 10.1097 /01.prs.0000299470.95855.ce. 41. Pelzer, M., M. Larsen, P.F. Friedrich, et al., Repopulation of vascularized bone allotransplants with recipient- derived cells: detection by laser capture microdissection and real-time PCR. Journal of Orthopaedic Research, 1514. 27 (11): p. 1514-20. 42. Muramatsu, K. and A.T. Bishop, Cell repopulation in vascularized bone grafts. J Orthop Res, 2001. 20 (4): p. 772-8. 43. Muramatsu, K. and A.T. Bishop, Microchimerism following vascularized bone allotransplantation. Transplant Proc, 2002. 34 (7): p. 2722-4. 44. Muramatsu, K., A.T. Bishop, T. Sunagawa, et al., Fate of Donor Cells in Vascularized Bone Grafts: Identification of Systemic Microchimerism by the Polymerase Chain Reaction. Plast Reconstr Surg, 2002. In press. 45. Muramatsu, K. and A.T. Bishop, Cell repopulation in vascularized bone grafts. Journal of Orthopaedic Research., 2002. 20 (4): p. 772-8. 46. Akoglu, B., S. Kriener, S. Martens, et al., Interleukin-2 in CD8+ T cells correlates with Banff score during organ rejection in liver transplant recipients. Clin Exp Med, 2009. 9 (4): p. 259-62. 47. Hofmann, G., M.H. Kirschner, F.D. Wagner, et al., Allogeneic vascularized transplantation of human femoral diaphyses and total knee joints--first clinical experiences. Transplant Proc, 1998. 30 (6): p. 2754-61. 48. Hofmann, G.O., C. Falk, and T. Wangemann, Immunological transformations in the recipient of grafted allogeneic human bone. Archives of Orthopaedic & Trauma Surgery, 1997. 116 (3): p. 143-50. 49. Hofmann, G.O. and M.H. Kirschner, Clinical experience in allogeneic vascularized bone and joint allografting. Microsurgery, 2000. 20 (8): p. 375-83. 50. Hofmann, G.O., M.H. Kirschner, L. Brauns, et al., Vascularized knee joint transplantation in man: a report on the first cases. Transplant International, 1998. 11 (1). 51. Hofmann, G.O., M.H. Kirschner, V. Buhren, et al., Allogenic vascularized transplantation of a human femoral diaphysis under cyclosporin A immunosuppression. Transpl Int, 1995. 8 (5): p. 418-9. 52. Hofmann, G.O., M.H. Kirschner, T. Wangemann, et al., Infections and immunological hazards of allogeneic bone transplantation. Arch Orthop Trauma Surg, 1995. 114 (3): p. 159-66. 53. Doi, K., S. Kawai, and M. Shigetomi, Congenital tibial pseudoarthrosis treated with vascularised bone allograft. Lancet, 1996. 347 (9006): p. 970-1. 54. Diefenbeck, M., F. Wagner, M.H. Kirschner, et al., Outcome of allogeneic vascularized knee transplants. Transplant International, 2007. 20 (5): p. 410-8.